RCG Belzoni is a medicare approved dialysis facility center in Belzoni, Mississippi and it has 9 dialysis stations. It is located in Humphreys county at 16451 U.s. Highway 49, Belzoni, MS, 39038. You can reach out to the office of RCG Belzoni at (662) 247-2255. This dialysis clinic is managed and/or owned by Fresenius Medical Care. RCG Belzoni has the following ownership type - Profit. It was first certified by medicare in March, 2009. The medicare id for this facility is 252573 and it accepts patients under medicare ESRD program.
Name | RCG Belzoni |
---|---|
Location | 16451 U.s. Highway 49, Belzoni, Mississippi |
No. of Dialysis Stations | 9 |
Medicare ID | 252573 |
Managed By | Fresenius Medical Care |
Ownership Type | Profit |
Late Shifts | No |
16451 U.s. Highway 49, Belzoni, Mississippi, 39038 | |
(662) 247-2255 | |
News Archive
New research indicates that giving patients a continuous low dose of an immune system booster, a method known as metronomic dosing, as part of a therapeutic prostate cancer vaccine strategy is safe and produces similar immune responses and fewer side effects than the more common dosing method, which is not well tolerated by many patients. This study, led by researchers at that National Cancer Institute (NCI), part of the National Institutes of Health, was published in the Aug. 15, 2008, issue of Clinical Cancer Research.
Food and health related research led by Professor Dick FitzGerald at the University of Limerick (UL) recently received a funding boost at the Science Foundation Ireland Technology Innovation Development Award (TIDA) programme announced by Minister for Research and Innovation, Seán Sherlock.
A home-based geriatric care program for low-income seniors resulted in higher-quality medical care, improvement in quality of life and fewer emergency department visits, but did not appear to prevent decline in physical functioning, according to a study in the December 12 issue of JAMA: The Journal of the American Medical Association.
A vitamin B6 derivative may help slow or prevent the progression of mild kidney disease in patients with diabetes, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
› Verified 1 days ago
NPI Number | 1700056538 |
Organization Name | Rcg Belzoni |
Doing Business As | Rcg Mississippi, Inc. |
Address | 16451 Us Hwy 49 Belzoni, Mississippi, 39038 |
Phone Number | (662) 247-2255 |
News Archive
New research indicates that giving patients a continuous low dose of an immune system booster, a method known as metronomic dosing, as part of a therapeutic prostate cancer vaccine strategy is safe and produces similar immune responses and fewer side effects than the more common dosing method, which is not well tolerated by many patients. This study, led by researchers at that National Cancer Institute (NCI), part of the National Institutes of Health, was published in the Aug. 15, 2008, issue of Clinical Cancer Research.
Food and health related research led by Professor Dick FitzGerald at the University of Limerick (UL) recently received a funding boost at the Science Foundation Ireland Technology Innovation Development Award (TIDA) programme announced by Minister for Research and Innovation, Seán Sherlock.
A home-based geriatric care program for low-income seniors resulted in higher-quality medical care, improvement in quality of life and fewer emergency department visits, but did not appear to prevent decline in physical functioning, according to a study in the December 12 issue of JAMA: The Journal of the American Medical Association.
A vitamin B6 derivative may help slow or prevent the progression of mild kidney disease in patients with diabetes, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
› Verified 1 days ago
Dialysis patients with Hemoglobin data | 25 |
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 20 |
News Archive
New research indicates that giving patients a continuous low dose of an immune system booster, a method known as metronomic dosing, as part of a therapeutic prostate cancer vaccine strategy is safe and produces similar immune responses and fewer side effects than the more common dosing method, which is not well tolerated by many patients. This study, led by researchers at that National Cancer Institute (NCI), part of the National Institutes of Health, was published in the Aug. 15, 2008, issue of Clinical Cancer Research.
Food and health related research led by Professor Dick FitzGerald at the University of Limerick (UL) recently received a funding boost at the Science Foundation Ireland Technology Innovation Development Award (TIDA) programme announced by Minister for Research and Innovation, Seán Sherlock.
A home-based geriatric care program for low-income seniors resulted in higher-quality medical care, improvement in quality of life and fewer emergency department visits, but did not appear to prevent decline in physical functioning, according to a study in the December 12 issue of JAMA: The Journal of the American Medical Association.
A vitamin B6 derivative may help slow or prevent the progression of mild kidney disease in patients with diabetes, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
› Verified 1 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular hemodialysis at the center | 42 |
Adult patient months included in Kt/V greater than or equal to 1.2 | 409 |
Percentage of adult patients getting regular hemodialysis at the center | 96 |
News Archive
New research indicates that giving patients a continuous low dose of an immune system booster, a method known as metronomic dosing, as part of a therapeutic prostate cancer vaccine strategy is safe and produces similar immune responses and fewer side effects than the more common dosing method, which is not well tolerated by many patients. This study, led by researchers at that National Cancer Institute (NCI), part of the National Institutes of Health, was published in the Aug. 15, 2008, issue of Clinical Cancer Research.
Food and health related research led by Professor Dick FitzGerald at the University of Limerick (UL) recently received a funding boost at the Science Foundation Ireland Technology Innovation Development Award (TIDA) programme announced by Minister for Research and Innovation, Seán Sherlock.
A home-based geriatric care program for low-income seniors resulted in higher-quality medical care, improvement in quality of life and fewer emergency department visits, but did not appear to prevent decline in physical functioning, according to a study in the December 12 issue of JAMA: The Journal of the American Medical Association.
A vitamin B6 derivative may help slow or prevent the progression of mild kidney disease in patients with diabetes, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
› Verified 1 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at RCG Belzoni with elevated calcium levels.
Patients with hypercalcemia | 44 |
Hypercalcemia patient months | 427 |
Patients with Serumphosphor | 43 |
Patients with Serumphosphor less than 3.5 mg/dL | 21 |
Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 22 |
Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 27 |
Patients with Serumphosphor from 5.6 to 7 mg/dL | 18 |
Patients with Serumphosphor greater than 7 mg/dL | 13 |
News Archive
New research indicates that giving patients a continuous low dose of an immune system booster, a method known as metronomic dosing, as part of a therapeutic prostate cancer vaccine strategy is safe and produces similar immune responses and fewer side effects than the more common dosing method, which is not well tolerated by many patients. This study, led by researchers at that National Cancer Institute (NCI), part of the National Institutes of Health, was published in the Aug. 15, 2008, issue of Clinical Cancer Research.
Food and health related research led by Professor Dick FitzGerald at the University of Limerick (UL) recently received a funding boost at the Science Foundation Ireland Technology Innovation Development Award (TIDA) programme announced by Minister for Research and Innovation, Seán Sherlock.
A home-based geriatric care program for low-income seniors resulted in higher-quality medical care, improvement in quality of life and fewer emergency department visits, but did not appear to prevent decline in physical functioning, according to a study in the December 12 issue of JAMA: The Journal of the American Medical Association.
A vitamin B6 derivative may help slow or prevent the progression of mild kidney disease in patients with diabetes, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
› Verified 1 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
Patients included in arterial venous fistula and catheter summaries | 42 |
Patient months included in arterial venous fistula and catheter summaries | 371 |
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 80 |
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 6 |
News Archive
New research indicates that giving patients a continuous low dose of an immune system booster, a method known as metronomic dosing, as part of a therapeutic prostate cancer vaccine strategy is safe and produces similar immune responses and fewer side effects than the more common dosing method, which is not well tolerated by many patients. This study, led by researchers at that National Cancer Institute (NCI), part of the National Institutes of Health, was published in the Aug. 15, 2008, issue of Clinical Cancer Research.
Food and health related research led by Professor Dick FitzGerald at the University of Limerick (UL) recently received a funding boost at the Science Foundation Ireland Technology Innovation Development Award (TIDA) programme announced by Minister for Research and Innovation, Seán Sherlock.
A home-based geriatric care program for low-income seniors resulted in higher-quality medical care, improvement in quality of life and fewer emergency department visits, but did not appear to prevent decline in physical functioning, according to a study in the December 12 issue of JAMA: The Journal of the American Medical Association.
A vitamin B6 derivative may help slow or prevent the progression of mild kidney disease in patients with diabetes, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
› Verified 1 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
Patients in facility's Hospitalization Summary | 38 |
Hospitalization Rate in facility | 126.8 (As Expected) |
Hospitalization Rate: Upper Confidence Limit | 277.8 |
Hospitalization Rate: Lower Confidence Limit | 61.2 |
News Archive
New research indicates that giving patients a continuous low dose of an immune system booster, a method known as metronomic dosing, as part of a therapeutic prostate cancer vaccine strategy is safe and produces similar immune responses and fewer side effects than the more common dosing method, which is not well tolerated by many patients. This study, led by researchers at that National Cancer Institute (NCI), part of the National Institutes of Health, was published in the Aug. 15, 2008, issue of Clinical Cancer Research.
Food and health related research led by Professor Dick FitzGerald at the University of Limerick (UL) recently received a funding boost at the Science Foundation Ireland Technology Innovation Development Award (TIDA) programme announced by Minister for Research and Innovation, Seán Sherlock.
A home-based geriatric care program for low-income seniors resulted in higher-quality medical care, improvement in quality of life and fewer emergency department visits, but did not appear to prevent decline in physical functioning, according to a study in the December 12 issue of JAMA: The Journal of the American Medical Association.
A vitamin B6 derivative may help slow or prevent the progression of mild kidney disease in patients with diabetes, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
› Verified 1 days ago
The rate of readmission show you whether patients who were being treated regularly at RCG Belzoni were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
Readmission Rate in facility | 9.6 (As Expected) |
Readmission Rate: Upper Confidence Limit | 30.7 |
Readmission Rate: Lower Confidence Limit | 1.4 |
News Archive
New research indicates that giving patients a continuous low dose of an immune system booster, a method known as metronomic dosing, as part of a therapeutic prostate cancer vaccine strategy is safe and produces similar immune responses and fewer side effects than the more common dosing method, which is not well tolerated by many patients. This study, led by researchers at that National Cancer Institute (NCI), part of the National Institutes of Health, was published in the Aug. 15, 2008, issue of Clinical Cancer Research.
Food and health related research led by Professor Dick FitzGerald at the University of Limerick (UL) recently received a funding boost at the Science Foundation Ireland Technology Innovation Development Award (TIDA) programme announced by Minister for Research and Innovation, Seán Sherlock.
A home-based geriatric care program for low-income seniors resulted in higher-quality medical care, improvement in quality of life and fewer emergency department visits, but did not appear to prevent decline in physical functioning, according to a study in the December 12 issue of JAMA: The Journal of the American Medical Association.
A vitamin B6 derivative may help slow or prevent the progression of mild kidney disease in patients with diabetes, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
› Verified 1 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at RCG Belzoni get infections in their blood each year compared to the number of infections expected for the center based on the national average.
Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
SIR: Upper Confidence Limit | 1.7 |
News Archive
New research indicates that giving patients a continuous low dose of an immune system booster, a method known as metronomic dosing, as part of a therapeutic prostate cancer vaccine strategy is safe and produces similar immune responses and fewer side effects than the more common dosing method, which is not well tolerated by many patients. This study, led by researchers at that National Cancer Institute (NCI), part of the National Institutes of Health, was published in the Aug. 15, 2008, issue of Clinical Cancer Research.
Food and health related research led by Professor Dick FitzGerald at the University of Limerick (UL) recently received a funding boost at the Science Foundation Ireland Technology Innovation Development Award (TIDA) programme announced by Minister for Research and Innovation, Seán Sherlock.
A home-based geriatric care program for low-income seniors resulted in higher-quality medical care, improvement in quality of life and fewer emergency department visits, but did not appear to prevent decline in physical functioning, according to a study in the December 12 issue of JAMA: The Journal of the American Medical Association.
A vitamin B6 derivative may help slow or prevent the progression of mild kidney disease in patients with diabetes, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
› Verified 1 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether RCG Belzoni's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
Patients in facility's Transfusion Summary | 34 |
Transfusion Rate in facility | 36.6 (As Expected) |
Transfusion Rate: Upper Confidence Limit | 127.5 |
Transfusion Rate: Lower Confidence Limit | 12.2 |
News Archive
New research indicates that giving patients a continuous low dose of an immune system booster, a method known as metronomic dosing, as part of a therapeutic prostate cancer vaccine strategy is safe and produces similar immune responses and fewer side effects than the more common dosing method, which is not well tolerated by many patients. This study, led by researchers at that National Cancer Institute (NCI), part of the National Institutes of Health, was published in the Aug. 15, 2008, issue of Clinical Cancer Research.
Food and health related research led by Professor Dick FitzGerald at the University of Limerick (UL) recently received a funding boost at the Science Foundation Ireland Technology Innovation Development Award (TIDA) programme announced by Minister for Research and Innovation, Seán Sherlock.
A home-based geriatric care program for low-income seniors resulted in higher-quality medical care, improvement in quality of life and fewer emergency department visits, but did not appear to prevent decline in physical functioning, according to a study in the December 12 issue of JAMA: The Journal of the American Medical Association.
A vitamin B6 derivative may help slow or prevent the progression of mild kidney disease in patients with diabetes, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
› Verified 1 days ago
The rate of mortality show you whether patients who were being treated regularly at RCG Belzoni lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
Patients in facility's Survival Summary | 156 |
Mortality Rate in facility | 21 (As Expected) |
Mortality Rate: Upper Confidence Limit | 33.2 |
Mortality Rate: Lower Confidence Limit | 12.4 |
News Archive
New research indicates that giving patients a continuous low dose of an immune system booster, a method known as metronomic dosing, as part of a therapeutic prostate cancer vaccine strategy is safe and produces similar immune responses and fewer side effects than the more common dosing method, which is not well tolerated by many patients. This study, led by researchers at that National Cancer Institute (NCI), part of the National Institutes of Health, was published in the Aug. 15, 2008, issue of Clinical Cancer Research.
Food and health related research led by Professor Dick FitzGerald at the University of Limerick (UL) recently received a funding boost at the Science Foundation Ireland Technology Innovation Development Award (TIDA) programme announced by Minister for Research and Innovation, Seán Sherlock.
A home-based geriatric care program for low-income seniors resulted in higher-quality medical care, improvement in quality of life and fewer emergency department visits, but did not appear to prevent decline in physical functioning, according to a study in the December 12 issue of JAMA: The Journal of the American Medical Association.
A vitamin B6 derivative may help slow or prevent the progression of mild kidney disease in patients with diabetes, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
› Verified 1 days ago
News Archive
New research indicates that giving patients a continuous low dose of an immune system booster, a method known as metronomic dosing, as part of a therapeutic prostate cancer vaccine strategy is safe and produces similar immune responses and fewer side effects than the more common dosing method, which is not well tolerated by many patients. This study, led by researchers at that National Cancer Institute (NCI), part of the National Institutes of Health, was published in the Aug. 15, 2008, issue of Clinical Cancer Research.
Food and health related research led by Professor Dick FitzGerald at the University of Limerick (UL) recently received a funding boost at the Science Foundation Ireland Technology Innovation Development Award (TIDA) programme announced by Minister for Research and Innovation, Seán Sherlock.
A home-based geriatric care program for low-income seniors resulted in higher-quality medical care, improvement in quality of life and fewer emergency department visits, but did not appear to prevent decline in physical functioning, according to a study in the December 12 issue of JAMA: The Journal of the American Medical Association.
A vitamin B6 derivative may help slow or prevent the progression of mild kidney disease in patients with diabetes, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.
› Verified 1 days ago